MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
2.440
+0.040
+1.67%
Closed 19:48 07/16 EDT
OPEN
2.400
PREV CLOSE
2.400
HIGH
2.510
LOW
2.400
VOLUME
114.77K
TURNOVER
0
52 WEEK HIGH
110.75
52 WEEK LOW
2.280
MARKET CAP
3.23M
P/E (TTM)
-0.0360
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 3d ago
Weekly Report: what happened at JAGX last week (0707-0711)?
Weekly Report · 3d ago
Jaguar Health initiates enrollment in study of Canalevia-CA1 drug for dogs
TipRanks · 07/10 12:50
Jaguar Health Inc. Advances European Approval Process for Canalevia with EMA Dossier Submission for General Diarrhea Treatment in Dogs
Reuters · 07/10 12:30
Jaguar Health announces coca access, benefit sharing agreement authorization
TipRanks · 07/08 13:10
Weekly Report: what happened at JAGX last week (0630-0704)?
Weekly Report · 07/07 11:42
Jaguar Animal Health Issues Series M Preferred Stock
TipRanks · 06/30 19:49
Jaguar Health announces initial proof-of-concept results on crofelemer
TipRanks · 06/30 14:54
More
About JAGX
Jaguar Health, Inc. is a commercial stage pharmaceuticals company. The Company is developing prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Its marketed drug Mytesi, (crofelemer 125 mg delayed-release tablets), is a first-in-class oral botanical drug product approved by the FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. Its Canalevia-CA1, crofelemer delayed-release tablets drug, is an oral plant-based prescription product that is FDA conditionally approved to treat chemotherapy-induced diarrhea in dogs. It has an exclusive distribution agreement for the sale of Gelclair. It is developing a pipeline of prescription drug product candidates to address unmet needs in gastrointestinal health.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.